My research interests lie at the intersection of translational medicine, molecular oncology, and computational science. I am particularly focused on pancreatic ductal adenocarcinoma and hepatobiliary disease, with an emphasis on developing and evaluating advanced therapeutic strategies, including investigational gene therapy and targeted delivery platforms.

A core part of my work is the use of artificial intelligence and machine learning to build research platforms for liver diseases, integrate complex clinical and biological datasets, and support biomarker discovery, disease stratification, and therapeutic decision making.

More broadly, I am interested in precision oncology, vector and payload optimisation, tissue-targeted therapeutic delivery, and the translation of preclinical discoveries into clinically meaningful interventions for pancreatic cancer, liver cancer, and liver failure.